Animal models of Williams syndrome

In recent years, researchers have generated a variety of mouse models in an attempt to dissect the contribution of individual genes to the complex phenotype associated with Williams syndrome (WS). The mouse genome is easily manipulated to produce animals that are copies of humans with genetic conditions, be it with null mutations, hypomorphic mutations, point mutations, or even large deletions encompassing many genes. The existing mouse models certainly seem to implicate hemizygosity for ELN, BAZ1B, CLIP2, and GTF2IRD1 in WS, and new mice with large deletions of the WS region are helping us to understand both the additive and potential combinatorial effects of hemizygosity for specific genes. However, not all genes that are haploinsufficient in humans prove to be so in mice and the effect of genetic background can also have a significant effect on the penetrance of many phenotypes. Thus although mouse models are powerful tools, the information garnered from their study must be carefully interpreted. Nevertheless, mouse models look set to provide a wealth of information about the neuroanatomy, neurophysiology and molecular pathways that underlie WS and in the future will act as essential tools for the development and testing of therapeutics. © 2010 Wiley‐Liss, Inc.

[1]  Kazuhiro Kikuchi,et al.  Essential Role of Fkbp6 in Male Fertility and Homologous Chromosome Pairing in Meiosis , 2003, Science.

[2]  M. Bayés,et al.  Mutational mechanisms of Williams-Beuren syndrome deletions. , 2003, American journal of human genetics.

[3]  Hideki Sugitani,et al.  Functional Rescue of Elastin Insufficiency in Mice by the Human Elastin Gene: Implications for Mouse Models of Human Disease , 2007, Circulation research.

[4]  S. Snyder,et al.  Action of TFII-I Outside the Nucleus as an Inhibitor of Agonist-Induced Calcium Entry , 2006, Science.

[5]  C. Almli,et al.  Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval , 2005, Development.

[6]  C. Fauth,et al.  Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams–Beuren syndrome neurocognitive profile , 2009, Journal of Medical Genetics.

[7]  Uta Francke,et al.  An atypical deletion of the Williams–Beuren syndrome interval implicates genes associated with defective visuospatial processing and autism , 2006, Journal of Medical Genetics.

[8]  Dean Y. Li,et al.  Distinct function of 2 chromatin remodeling complexes that share a common subunit, Williams syndrome transcription factor (WSTF) , 2009, Proceedings of the National Academy of Sciences.

[9]  J. Ellis,et al.  Transgenic mouse overexpressing syntaxin-1A as a diabetes model. , 2005, Diabetes.

[10]  F. V. D. Staay,et al.  Behavioural phenotyping of mouse mutants , 2001, Behavioural Brain Research.

[11]  R. Behringer,et al.  Goosecoid is not an essential component of the mouse gastrula organizer but is required for craniofacial and rib development. , 1995, Development.

[12]  T. Bjørnland,et al.  Neurocranial morphology and growth in Williams syndrome. , 2005, European journal of orthodontics.

[13]  J. Bregman,et al.  Multisystem study of 20 older adults with Williams syndrome , 2004, American journal of medical genetics. Part A.

[14]  S. Papson,et al.  “Model” , 1981 .

[15]  J. Lupski,et al.  Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike. , 2007, American journal of human genetics.

[16]  B. Gulanski,et al.  High prevalence of diabetes and pre‐diabetes in adults with Williams syndrome , 2010, American journal of medical genetics. Part C, Seminars in medical genetics.

[17]  Hiromichi Nagasawa,et al.  RETRACTED: The Chromatin-Remodeling Complex WINAC Targets a Nuclear Receptor to Promoters and Is Impaired in Williams Syndrome , 2003, Cell.

[18]  Ursula Bellugi,et al.  Williams syndrome: neuronal size and neuronal-packing density in primary visual cortex. , 2002, Archives of neurology.

[19]  A Mari,et al.  Detection of an atypical 7q11.23 deletion in Williams syndrome patients which does not include the STX1A and FZD3 genes , 1999, Journal of medical genetics.

[20]  Mouse Genome Sequencing Consortium.  Initial sequencing and comparative analysis of the mouse genome , 2002, Nature.

[21]  M. Kähkönen,et al.  Cardiovascular manifestations in 75 patients with Williams syndrome , 2002, Journal of medical genetics.

[22]  I. Weissman,et al.  Frizzled 9 knock-out mice have abnormal B-cell development. , 2005, Blood.

[23]  Stephen J. Palmer,et al.  Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development. , 2007, Gene expression patterns : GEP.

[24]  A. Winterpacht,et al.  Partial deletion of the critical 1.5 Mb interval in Williams-Beuren syndrome , 2003, Journal of medical genetics.

[25]  Ananda L Roy,et al.  Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development , 2009, Proceedings of the National Academy of Sciences.

[26]  T. Denning,et al.  Negative regulation of T cell activation and autoimmunity by the transmembrane adaptor protein LAB. , 2006, Immunity.

[27]  B. Malissen,et al.  Negative Regulation of Mast Cell Signaling and Function by the Adaptor LAB/NTAL , 2004, The Journal of experimental medicine.

[28]  Patricia Spallone,et al.  Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.

[29]  Jianzhi Zhang,et al.  Null mutations in human and mouse orthologs frequently result in different phenotypes , 2008, Proceedings of the National Academy of Sciences.

[30]  Marleen Verhoye,et al.  Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice , 2002, Nature Genetics.

[31]  P. Gruss,et al.  Targeted mutation of the murine goosecoid gene results in craniofacial defects and neonatal death. , 1995, Development.

[32]  P. Fletcher,et al.  Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1‐targeted mice , 2008, Genes, brain, and behavior.

[33]  S. Thorgeirsson,et al.  Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome. , 2001, Genomics.

[34]  H. Moser,et al.  Dendritic anomalies in disorders associated with mental retardation. , 1999, Cerebral cortex.

[35]  R. Dyck,et al.  Syntaxin 1A is required for normal in utero development. , 2008, Biochemical and biophysical research communications.

[36]  R. Mecham,et al.  Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.

[37]  T. Bruxner,et al.  A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development , 2008, Genome Biology.

[38]  F. Ruddle,et al.  Repression of TFII-I-dependent transcription by nuclear exclusion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Peter Hammond,et al.  GTF2IRD1 in Craniofacial Development of Humans and Mice , 2005, Science.

[40]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[41]  C. McKerlie,et al.  Mouse-based phenogenomics for modelling human disease. , 2001, Trends in molecular medicine.

[42]  Yukio Horikawa,et al.  ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. , 2008, Endocrine journal.

[43]  E. Lambe,et al.  Enhanced prefrontal serotonin 5-HT1A currents in a mouse model of Williams-Beuren syndrome with low innate anxiety , 2010, Journal of Neurodevelopmental Disorders.

[44]  E. Mass,et al.  Craniofacial morphology of children with Williams syndrome. , 1993, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[45]  Yan Liu,et al.  Positive and Negative Regulation of FcɛRI-Mediated Signaling by the Adaptor Protein LAB/NTAL , 2004, The Journal of experimental medicine.

[46]  K. Iizuka,et al.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C A Morris,et al.  Natural history of Williams syndrome: physical characteristics. , 1988, The Journal of pediatrics.

[48]  Karl Deisseroth,et al.  Induced chromosome deletions cause hypersociability and other features of Williams–Beuren syndrome in mice , 2009, EMBO molecular medicine.

[49]  Stephen J. Palmer,et al.  Negative Autoregulation of GTF2IRD1 in Williams-Beuren Syndrome via a Novel DNA Binding Mechanism* , 2009, The Journal of Biological Chemistry.

[50]  Mica Ohara-Imaizumi,et al.  Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis , 2007, The Journal of cell biology.

[51]  A. Karmiloff-Smith,et al.  Discriminating power of localized three-dimensional facial morphology. , 2005, American journal of human genetics.

[52]  Niels Galjart,et al.  LIMK1 and CLIP-115: linking cytoskeletal defects to Williams syndrome. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[53]  J. Macdonald,et al.  Abnormal Spine Morphology and Enhanced LTP in LIMK-1 Knockout Mice , 2002, Neuron.

[54]  A. Nagy,et al.  Mouse models of human disease , 2000, Clinical genetics.

[55]  Keiji Tanaka,et al.  Analysis of Knock-Out Mice to Determine the Role of HPC-1/Syntaxin 1A in Expressing Synaptic Plasticity , 2006, The Journal of Neuroscience.

[56]  Alexandre Reymond,et al.  An atypical 7q11.23 deletion in a normal IQ Williams–Beuren syndrome patient , 2010, European Journal of Human Genetics.

[57]  A. Holmes,et al.  Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice , 2002, Genes, brain, and behavior.

[58]  S. Mondillo,et al.  New Findings concerning Cardiovascular Manifestations emerging from Long-term Follow-up of 150 patients with the Williams-Beuren-Beuren syndrome , 2009, Cardiology in the Young.

[59]  Mark Noble,et al.  LIM-kinase1 Hemizygosity Implicated in Impaired Visuospatial Constructive Cognition , 1996, Cell.

[60]  C. Mervis,et al.  GTF2I hemizygosity implicated in mental retardation in Williams syndrome: Genotype–phenotype analysis of five families with deletions in the Williams syndrome region , 2003, American journal of medical genetics. Part A.